Cephalosporin-resistant Escherichia coli isolated from farm workers and pigs in northern Vietnam

Trop Med Int Health. 2018 Apr;23(4):415-424. doi: 10.1111/tmi.13054.

Abstract

Objective: Antimicrobial-resistant bacteria may be transmitted between farm workers and livestock. This study aimed to determine and compare the prevalence and the genetic determinants of cefotaxime-resistant and ESBL-producing Escherichia coli in faecal isolates from workers and pigs at 100 farms in northern Vietnam.

Methods: Farmers were interviewed about antimicrobial usage in livestock. Escherichia coli isolated on MacConkey agar containing 2 mg/l of cefotaxime (CTX) were tested for susceptibility to different cephalosporins by disc diffusion and screened for occurrence of ESBL-encoding genes by PCR.

Results: Antimicrobial usage was widespread and included classes regarded of critical or high importance in human medicine. Dosages were 0.5-2 times higher than recommended, and antimicrobials were often administered right until slaughter. Prevalence of CTX-resistant E. coli was 86% in farm workers and 89% in pigs. In 76% of farms, CTX-resistant E. coli were shared by pigs and farm workers. ESBL-producing E. coli were detected from pigs and workers at 66 and 69 farms, respectively. The ESBL phenotype was mainly mediated by CTX-M and to a lesser extent by TEM. Occurrence of blaCTX-M was similar in E. coli from pigs (66.7%) and humans (68.5%).

Conclusion: The high occurrence of ESBL-producing E. coli in pig farmers and pigs could present a risk for spillover of these bacteria from pig farms into the community. Genomic studies are needed to elucidate reservoirs and transmission routes of ESBL-producing E. coli at livestock farms.

Keywords: BLSE; Agriculteurs; CTX-M; ESBL; Porcs; Vietnam; cephalosporin resistance; farmers; pigs; résistance aux céphalosporines.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animal Husbandry / methods
  • Animals
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / therapeutic use
  • Cefotaxime / administration & dosage
  • Cefotaxime / pharmacology
  • Cefotaxime / therapeutic use
  • Cephalosporins / administration & dosage
  • Cephalosporins / pharmacology*
  • Cephalosporins / therapeutic use
  • Disease Reservoirs
  • Escherichia coli / drug effects*
  • Escherichia coli / genetics
  • Escherichia coli / growth & development
  • Escherichia coli / metabolism
  • Escherichia coli Infections / drug therapy
  • Escherichia coli Infections / microbiology*
  • Escherichia coli Infections / veterinary
  • Farmers*
  • Farms
  • Humans
  • Livestock / microbiology
  • Microbial Sensitivity Tests
  • Occupational Exposure
  • Phenotype
  • Polymerase Chain Reaction
  • Surveys and Questionnaires
  • Swine / microbiology*
  • Zoonoses / drug therapy
  • beta-Lactam Resistance*
  • beta-Lactamases / metabolism

Substances

  • Anti-Bacterial Agents
  • Cephalosporins
  • beta-Lactamases
  • Cefotaxime